| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 公司成立于2010年,公司于2012年4月正式更名为杭州安杰思医学科技有限公司，一直致力于微创介入诊疗领域产品和手术方案的设计与开发，是一家集研发、生产、销售和服务为一-体的国家高新技术企业。公司秉持“创造、坚持、分享”的核心价值观,为患者和临床医生提供更安全、更高效的内镜微创诊疗器械,帮助病人减少痛苦,降低医疗成本,安杰思致力于打造一家”让员工幸福，客户满意,股东放心”的幸福家园,一家受员工尊重、竞争对手尊重以及社会尊重的优秀企业。 | ||||||||||||||||||||||||
| Main Business | 内镜微创诊疗器械的研发、生产与销售。 | ||||||||||||||||||||||||
| Legal Representative | 张承 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 张勤华 | ||||||||||||||||||||||||
| Solicitors | 北京德恒律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0571-88775216 | ||||||||||||||||||||||||
| Fax No | 0571-87671225 | ||||||||||||||||||||||||
| Website | www.bioags.com | ||||||||||||||||||||||||
| IR@bioags.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 19/05/2023 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 4.190 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 1.450 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 38.158 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.591B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |